Back to search results

Cataract Surgery Outcomes with CT LUCIA Lens After Laser Vision Correction

This study is looking at how well people see after cataract surgery when they have previously had laser vision correction (like LASIK or PRK) and receive the CT LUCIA 621P intraocular lens (IOL). Researchers want to see how accurately the lens corrects vision. You might be able to join if you are at least 18 years old and had laser vision correction at least one year ago. The study will measure how close your vision correction is to what was predicted, three months after surgery. The current recruitment status is unclear.

Study design
This is an observational study that will enroll up to 30 participants across up to three U.S. sites. It is a post-approval study, meaning the CT LUCIA 621P IOL is already approved.
What's involved
You would undergo routine cataract surgery with the CT LUCIA 621P IOL implanted in both eyes. Your vision will be assessed over a 3-month follow-up period.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months after surgery to assess visual outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07084545

Evaluation of Cataract Surgery Outcomes in Patients With Prior Laser Vision Correction Implanted With the CT LUCIA Lens

Recruiting
Not specifiedAges 18+Observational
Carl Zeiss Meditec AG
~30 participants
Updated 2025-07-24 on ClinicalTrials.gov
What's tested:CT LUCIA 621P Intraocular Lens Implantation

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean Prediction Error (PE)
Measured over 3 months postoperatively
+5 more outcomes measured

Conditions

Postoperative Visual Outcomes Following Cataract Surgery in Patients With Prior Myopic Corneal Laser Vision Correction

Explore related trials

Cataract

Where it's being run

2 sites across 2 states
Texas1
Virginia1

Who to contact

Henry Heering
[email protected]
949-293-0520
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Mean Prediction Error (PE)3 months postoperatively

    The average difference between postoperative manifest refraction spherical equivalent (MRSE) and predicted MRSE based on IOLMaster 700 with Barrett True-K with TK formula.

  • Median Prediction Error (PE)3 months postoperatively

    The median difference between postoperative MRSE and predicted MRSE based on IOLMaster 700 with Barrett True-K with TK formula.

  • Absolute Prediction Error (PE)3 months postoperatively

    The absolute value of the difference between postoperative MRSE and predicted MRSE based on IOLMaster 700 with Barrett True-K with TK formula.

  • Percentage of Eyes Within ±0.25 D of Predicted MRSE3 months postoperatively

    The proportion of eyes achieving postoperative MRSE within ±0.25 D of the predicted MRSE based on IOLMaster 700 with Barrett True-K with TK formula.

  • Percentage of Eyes Within ±0.50 D of Predicted MRSE3 months postoperatively

    The proportion of eyes achieving postoperative MRSE within ±0.50 D of the predicted MRSE based on IOLMaster 700 with Barrett True-K with TK formula.

  • Percentage of Eyes Within ±1.00 D of Predicted MRSE3 months postoperatively

    The proportion of eyes achieving postoperative MRSE within ±1.00 D of the predicted MRSE based on IOLMaster 700 with Barrett True-K with TK formula.